A direct morphometric comparison of five labeling protocols for multi-atlas driven automatic segmentation of the

Sean M Nestor1, Erin Gibson2, Fu-Qiang Gao3

  • 1LC Campbell Cognitive Neurology Research Unit, University of Toronto, Canada; Heart and Stroke Foundation Centre for Stroke Recovery, University of Toronto, Canada; Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Canada; University of Toronto, Institute of Medical Sciences, University of Toronto, University of Toronto, Canada; MD/PhD Program, Faculty of Medicine, University of Toronto, University of Toronto, Canada.

Neuroimage
|November 13, 2012
PubMed

Insights

Choosing the right hippocampal labeling protocol is crucial for accurate Alzheimer's disease (AD) diagnosis and clinical trials. More inclusive protocols improve accuracy and sensitivity in distinguishing disease stages.

Area of Science:

  • Neuroimaging
  • Alzheimer's Disease Research
  • Medical Diagnostics

Background:

  • Structural MRI-based hippocampal volumetry is vital for Alzheimer's disease (AD) diagnosis and therapeutic trial efficacy.
  • Morphological heterogeneity in AD complicates accurate hippocampal demarcation.
  • Automated volumetry using multi-template fusion offers high accuracy and reproducibility.

Purpose of the Study:

  • To evaluate the performance of five common hippocampal labeling protocols for automated multi-atlas based segmentation in AD.
  • To compare the accuracy and sensitivity of different protocols in distinguishing between normal elders, mild cognitive impairment (MCI), and AD.
  • To determine which protocols are most suitable for powering clinical trials in MCI and AD.

Main Methods:

  • A fully automated segmentation technique was developed and tested using data from the Sunnybrook Longitudinal Dementia Study and the Alzheimer's Disease Neuroimaging Initiative 1 (ADNI-1).
  • Five distinct hippocampal labeling protocols were implemented and compared head-to-head.
  • Manual tracings by a single operator served as the 'ground truth' for comparison.

Main Results:

  • All tested protocols differentiated between normal elders, MCI, and AD, showing comparable memory correlations.
  • More inclusive protocols accurately distinguished between stable MCI and MCI-to-AD converters.
  • Protocols incorporating posterior anatomy and dorsal white matter achieved superior Dice Similarity Coefficients (0.87-0.89) and required smaller sample sizes for clinical trials.

Conclusions:

  • The selection of a hippocampal labeling protocol significantly impacts automated segmentation accuracy and biomarker performance in AD.
  • Protocols including more posterior and dorsal white matter regions demonstrate higher accuracy and efficiency for clinical trials.
  • Accuracy differences among protocols were most pronounced in AD subjects compared to MCI and normal elders.

Related Concept Videos